Temsirolimus (CCI-770, Torisel) Combined With Cetuximab in Cetuximab-Refractory Colorectal Cancer

NCT00593060 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

35

Enrollment

OTHER

Sponsor class

Conditions

Colorectal Cancer
Colorectal Adenocarcinoma

Interventions

DRUG: Temsirolimus
DRUG: Cetuximab

Sponsor

Jeffrey W. Clark, MD

Collaborators

[object Object]
[object Object]
[object Object]